I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
U.S. Food and Drug Administration Approval Summary: Erlotin..:
Khozin, Sean
;
Blumenthal, Gideon M.
;
Jiang, Xiaoping
...
The Oncologist. 19 (2014) 7 - p. 774-779 , 2014
Link:
https://doi.org/10.1634/theoncologist.2014-0089
RT Journal T1
U.S. Food and Drug Administration Approval Summary: Erlotinib for the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 19 Deletions or Exon 21 (L858R) Substitution Mutations
UL https://suche.suub.uni-bremen.de/peid=cr-10.1634_theoncologist.2014-0089&Exemplar=1&LAN=DE A1 Khozin, Sean A1 Blumenthal, Gideon M. A1 Jiang, Xiaoping A1 He, Kun A1 Boyd, Karen A1 Murgo, Anthony A1 Justice, Robert A1 Keegan, Patricia A1 Pazdur, Richard PB Oxford University Press (OUP) YR 2014 SN 1083-7159 SN 1549-490X JF The Oncologist VO 19 IS 7 SP 774 OP 779 LK http://dx.doi.org/https://doi.org/10.1634/theoncologist.2014-0089 DO https://doi.org/10.1634/theoncologist.2014-0089 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)